Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats' Disease.

Mohamed NowaraYousef Ahmed FouadIhab Abdel AzizAhmed M HabibMariam Al-FekyHisham Hassan

Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)

Combining intravitreal ranibizumab injection with ablation therapy is effective in managing exudative Coats' disease. External drainage should be preserved for when ablation therapy is not feasible. Future prospective trials with pre-defined outcomes are required.

Keyphrases

age related macular degeneration
diabetic retinopathy
vascular endothelial growth factor
type diabetes
radiofrequency ablation
stem cells
optical coherence tomography
metabolic syndrome
catheter ablation
skeletal muscle
cell therapy
insulin resistance